CG Oncology (CGON) Total Current Liabilities (2023 - 2026)

CG Oncology has reported Total Current Liabilities for 4 years, with the latest figure at $35.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 55.53% year-over-year to $35.2 million; the trailing twelve-month figure through Mar 2026 stood at $35.2 million (up 55.53% YoY), and the FY2025 full-year result was $30.8 million, up 44.31% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $35.2 million, up from $30.8 million in the prior quarter.
• The five-year high for Total Current Liabilities was $35.2 million in Q1 2026, with the low at $10.0 million in Q1 2024.
• Historically, Total Current Liabilities has averaged $22.3 million across 4 years, with a median of $22.0 million in 2024.
• The largest YoY upside for Total Current Liabilities was 156.31% in 2025 against a maximum downside of 44.31% in 2025.
• CG Oncology's Total Current Liabilities stood at $14.3 million in 2023, then soared by 49.91% to $21.4 million in 2024, then surged by 44.31% to $30.8 million in 2025, then grew by 14.2% to $35.2 million in 2026.
• The last three Total Current Liabilities figures came in at $35.2 million (Q1 2026), $30.8 million (Q4 2025), and $30.5 million (Q3 2025), per Business Quant data.